152 related articles for article (PubMed ID: 23726804)
21. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction.
Çanga A; Durakoğlugil ME; Erdoğan T; Kirbaş A; Yilmaz A; Çiçek Y; Ergül E; Çetin M; Kocaman SA
J Cardiol; 2012 Nov; 60(5):355-60. PubMed ID: 22727437
[TBL] [Abstract][Full Text] [Related]
24. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
Park YJ; Shin YJ; Kim WU; Cho CS
Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
[TBL] [Abstract][Full Text] [Related]
25. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
[TBL] [Abstract][Full Text] [Related]
26. Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis.
Asanuma YF; Shimada Y; Kouzu N; Yokota K; Nakajima K; Sato K; Akiyama Y; Isozaki M; Mikami AS; Kobayashi H; Mimura T
Mod Rheumatol; 2013 Mar; 23(2):269-75. PubMed ID: 22584471
[TBL] [Abstract][Full Text] [Related]
27. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis.
Dessein PH; López-Mejias R; González-Juanatey C; Genre F; Miranda-Filloy JA; Llorca J; González-Gay MA
J Rheumatol; 2014 Mar; 41(3):429-36. PubMed ID: 24488413
[TBL] [Abstract][Full Text] [Related]
28. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
Asanuma Y; Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
Atherosclerosis; 2007 Dec; 195(2):e135-41. PubMed ID: 17570371
[TBL] [Abstract][Full Text] [Related]
29. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
[TBL] [Abstract][Full Text] [Related]
30. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients.
Song TJ; Kim J; Yang SH; Park JH; Lee HS; Nam CM; Lee OH; Kim YD; Nam HS; Heo JH
Biomarkers; 2012 Dec; 17(8):738-44. PubMed ID: 23030274
[TBL] [Abstract][Full Text] [Related]
31. Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus.
Kiani AN; Aukrust P; Ueland T; Hollan I; Barr E; Magder LS; Petri M
Lupus; 2017 Jul; 26(8):865-870. PubMed ID: 27927880
[TBL] [Abstract][Full Text] [Related]
32. Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease.
Esteghamati A; Sheikhbahaei S; Hafezi-Nejad N; Mousavizadeh M; Noshad S; Gilani Larimi N; Azizi R; Nakhjavani M
Arch Iran Med; 2014 Sep; 17(9):596-601. PubMed ID: 25204474
[TBL] [Abstract][Full Text] [Related]
33. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
34. TNF-related apoptosis-inducing ligand and cardiovascular disease in rheumatoid arthritis.
Dessein PH; Lopez-Mejias R; Ubilla B; Genre F; Corrales A; Hernandez JL; Ferraz-Amaro I; Tsang L; Pina T; Llorca J; Blanco R; Gonzalez-Juanatey C; Gonzalez-Gay MA
Clin Exp Rheumatol; 2015; 33(4):491-7. PubMed ID: 25962765
[TBL] [Abstract][Full Text] [Related]
35. A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.
Morena M; Dupuy AM; Jaussent I; Vernhet H; Gahide G; Klouche K; Bargnoux AS; Delcourt C; Canaud B; Cristol JP
Nephrol Dial Transplant; 2009 Nov; 24(11):3389-97. PubMed ID: 19574342
[TBL] [Abstract][Full Text] [Related]
36. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
[TBL] [Abstract][Full Text] [Related]
37. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
[TBL] [Abstract][Full Text] [Related]
38. Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.
Giovannini S; Tinelli G; Biscetti F; Straface G; Angelini F; Pitocco D; Mucci L; Landolfi R; Flex A
Cardiovasc Diabetol; 2017 Aug; 16(1):99. PubMed ID: 28789654
[TBL] [Abstract][Full Text] [Related]
39. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity.
Venuraju SM; Yerramasu A; Corder R; Lahiri A
J Am Coll Cardiol; 2010 May; 55(19):2049-61. PubMed ID: 20447527
[TBL] [Abstract][Full Text] [Related]
40. Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions.
Yang Q; Lu S; Chen Y; Song X; Jin Z; Yuan F; Li H; Zhou Y; Chen F; Huo Y
Clin Cardiol; 2011 Jul; 34(7):447-53. PubMed ID: 21678453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
